3rd Apr 2024 08:00
RNS Number : 0207J
Oxford Cannabinoid Tech.Holdings
03 April 2024
OCT Company Update with Doceo
Oxford Cannabinoid Technologies Holdings plc (LSE:OCTP), a clinical stage biopharmaceutical company focused on the development and commercialisation of innovative cannabinoid medicines, is pleased to share the following Company Update video with Doceo.
Clarissa Sowemimo-Coker, Chief Executive Officer, discusses the significant unmet need for non-addictive treatments to help people living with debilitating conditions in a global pain market that is estimated to be worth £75bn by 2027.
Your browser does not support HTML5 video.
For further information on Doceo please visit www.doceo.tv or contact the team on [email protected]
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy.
END
NRAZZGGDDZFGDZM
Related Shares:
OCTP.L
